Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The work presented here demonstrates that human complement factor H is an adhesion ligand for human neutrophils but not for eosinophils. The adherence of polymorphonuclear leukocytes (PMNs) to plastic wells coated with
factor H
depended on divalent metal ions and was augmented by C5a and TNF-alpha. PMN adhesion to
factor H
in the presence or absence of C5a was blocked specifically by mAbs against CD11b or CD18. Affinity purification using
factor H
Sepharose followed by immunoprecipitation using mAbs to various integrin chains identified Mac-1 (CD11b/CD18) as a
factor H
binding receptor. The presence of surface bound
factor H
enhanced neutrophil activation resulting in a two- to fivefold increase in the generation of hydrogen peroxide by PMNs stimulated by C5a or TNF-alpha. When
factor H
was mixed with PMNs, 1.4 to 3.8-fold more cells adhered to immobilized heparin or chondroitin A. In addition, augmented adhesion of PMNs was measured when
factor H
, but not
HSA
or C9, was absorbed to wells that were first coated with heparin or chondroitin A. The adhesion of PMNs to glycosaminoglycan-
factor H
was blocked by mAbs to CD11b and CD18. These studies demonstrate that
factor H
is an adhesion molecule for human neutrophils and suggest that the interaction of
factor H
with glycosaminoglycans may facilitate the tethering of this protein in tissues allowing
factor H
to serve as a neutrophil adhesion ligand in vivo.
...
PMID:Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18). 955 16
Activation of complement is known to accompany burn injury. To study deposition of complement proteins within tissue traumatized by burn we employed the technique of intravital microscopy using a murine dorsal skinfold chamber model. C3,
factor H
, factor B,
HSA
, and transferrin were labeled fluorescently and injected into the tail vein of mice which had been subjected to a small third degree burn within the skin fold. Only C3 and
factor H
deposited within blood vessels of the traumatized tissue. Binding was specific because it occurred only in and proximal to burn sites, and neither C3 nor
factor H
was observed to accumulate in blood vessels of healthy tissue. Furthermore, fluorescently labelled
HSA
, factor B, and transferrin all failed to deposit at or around burn loci. The deposition of C3 and
factor H
occurred within 10 min of injury and was intravascular occurring in major blood vessels, capillaries, and post-capillary venules, with little evidence of accumulation in the interstitium. Since both C3 fragments and
factor H
are recognized as adhesion molecules by granulocyte receptors, these deposited proteins could promote leukocyte accumulation, thereby contributing to an initiation of an inflammatory cascade at a site of burn injury.
...
PMID:Deposition of complement C3 and factor H in tissue traumatized by burn injury. 1040 80